Correlation Between Sakar Healthcare and India Glycols

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sakar Healthcare and India Glycols at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sakar Healthcare and India Glycols into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sakar Healthcare Limited and India Glycols Limited, you can compare the effects of market volatilities on Sakar Healthcare and India Glycols and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sakar Healthcare with a short position of India Glycols. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sakar Healthcare and India Glycols.

Diversification Opportunities for Sakar Healthcare and India Glycols

0.29
  Correlation Coefficient

Modest diversification

The 3 months correlation between Sakar and India is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Sakar Healthcare Limited and India Glycols Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on India Glycols Limited and Sakar Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sakar Healthcare Limited are associated (or correlated) with India Glycols. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of India Glycols Limited has no effect on the direction of Sakar Healthcare i.e., Sakar Healthcare and India Glycols go up and down completely randomly.

Pair Corralation between Sakar Healthcare and India Glycols

Assuming the 90 days trading horizon Sakar Healthcare Limited is expected to under-perform the India Glycols. But the stock apears to be less risky and, when comparing its historical volatility, Sakar Healthcare Limited is 1.41 times less risky than India Glycols. The stock trades about -0.03 of its potential returns per unit of risk. The India Glycols Limited is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  119,840  in India Glycols Limited on September 1, 2024 and sell it today you would earn a total of  7,755  from holding India Glycols Limited or generate 6.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy95.45%
ValuesDaily Returns

Sakar Healthcare Limited  vs.  India Glycols Limited

 Performance 
       Timeline  
Sakar Healthcare 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sakar Healthcare Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward-looking signals, Sakar Healthcare is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
India Glycols Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days India Glycols Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, India Glycols is not utilizing all of its potentials. The newest stock price mess, may contribute to short-term losses for the institutional investors.

Sakar Healthcare and India Glycols Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sakar Healthcare and India Glycols

The main advantage of trading using opposite Sakar Healthcare and India Glycols positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sakar Healthcare position performs unexpectedly, India Glycols can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in India Glycols will offset losses from the drop in India Glycols' long position.
The idea behind Sakar Healthcare Limited and India Glycols Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes